Fiasp – going off-label. Being intentionally non-compliant!
Warning: What is discussed in this post is not recommended by the manufacturer and not aligned with the European Medicines Agency sign off for Fiasp. […]
Novo Nordisk
Novo Nordisk FIAsp. Announced and with us shortly in the UK, + whatever happened to BC Lispro…? #fasterinsulinplease
The first of the faster insulins that we saw a great deal of detail about at EASD 2016 is due to arrive at wholesalers near […]
Lantus: Lethal or Lifesaver? #DOC #gbdoc
Summary Following issues I experienced with Lantus (Insulin Glargine) in November 2014, I spent some time researching it, looking at absorption and pharmacokinetics and other […]